Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution.

Matthews L, Marasco R, Jenkinson M, Küker W, Luppe S, Leite MI, Giorgio A, De Stefano N, Robertson N, Johansen-Berg H, Evangelou N, Palace J.

Neurology. 2013 Apr 2;80(14):1330-7. doi: 10.1212/WNL.0b013e3182887957. Epub 2013 Mar 13.

2.

Neuromyelitis Optica Spectrum Disorders.

Akaishi T, Nakashima I, Sato DK, Takahashi T, Fujihara K.

Neuroimaging Clin N Am. 2017 May;27(2):251-265. doi: 10.1016/j.nic.2016.12.010. Epub 2017 Feb 9. Review.

PMID:
28391784
3.

Overlapping CNS inflammatory diseases: differentiating features of NMO and MS.

Juryńczyk M, Craner M, Palace J.

J Neurol Neurosurg Psychiatry. 2015 Jan;86(1):20-5. doi: 10.1136/jnnp-2014-308984. Epub 2014 Sep 23. Review.

PMID:
25248365
4.

Clinical spectrum and treatment of neuromyelitis optica spectrum disorders: evolution and current status.

Sato DK, Lana-Peixoto MA, Fujihara K, de Seze J.

Brain Pathol. 2013 Nov;23(6):647-60. doi: 10.1111/bpa.12087. Review.

PMID:
24118482
5.

Neuromyelitis Spectrum Disorders.

Weinshenker BG, Wingerchuk DM.

Mayo Clin Proc. 2017 Apr;92(4):663-679. doi: 10.1016/j.mayocp.2016.12.014. Review.

PMID:
28385199
6.

Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature.

Jarius S, Paul F, Franciotta D, de Seze J, Münch C, Salvetti M, Ruprecht K, Liebetrau M, Wandinger KP, Akman-Demir G, Melms A, Kristoferitsch W, Wildemann B.

Mult Scler. 2012 Aug;18(8):1135-43. doi: 10.1177/1352458511431728. Epub 2011 Dec 19. Review.

PMID:
22183934
7.

MRI characteristics of neuromyelitis optica spectrum disorder: an international update.

Kim HJ, Paul F, Lana-Peixoto MA, Tenembaum S, Asgari N, Palace J, Klawiter EC, Sato DK, de Seze J, Wuerfel J, Banwell BL, Villoslada P, Saiz A, Fujihara K, Kim SH; Guthy-Jackson Charitable Foundation NMO International Clinical Consortium & Biorepository.

Neurology. 2015 Mar 17;84(11):1165-73. doi: 10.1212/WNL.0000000000001367. Epub 2015 Feb 18. Review.

8.

Seronegative Neuromyelitis Optica Spectrum--the challenges on disease definition and pathogenesis.

Sato DK, Callegaro D, Lana-Peixoto MA, Nakashima I, Fujihara K.

Arq Neuropsiquiatr. 2014 Jun;72(6):445-50. Review.

9.

Galactorrhea in a Patient With Aquaporin-4 Antibody-positive Neuromyelitis Optica Spectrum Disorder: A Case Report and Review of the Literature.

Watanabe M, Furusho K, Takahashi T, Tamaoka A.

Neurologist. 2015 Dec;20(6):101-3. doi: 10.1097/NRL.0000000000000061. Review.

PMID:
26671741
10.

[Clinical concept, etiology and pathology of neuromyelitis optica].

Kurosawa K, Fujihara K.

Nihon Rinsho. 2014 Nov;72(11):1897-902. Review. Japanese.

PMID:
25518368
11.

The expanded spectrum of neuromyelitis optica: evidences for a new definition.

Lana-Peixoto MA, Callegaro D.

Arq Neuropsiquiatr. 2012 Oct;70(10):807-13. Review.

12.

Neuromyelitis optica spectrum disorder (NMOSD): A new concept.

de Sèze J, Kremer L, Collongues N.

Rev Neurol (Paris). 2016 Apr-May;172(4-5):256-62. doi: 10.1016/j.neurol.2016.03.003. Epub 2016 May 4. Review.

PMID:
27157418

Supplemental Content

Support Center